- Home
- CLDI vs AMOD Comparison
CLDI vs AMOD Comparison
Compare CLDI & AMOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- AMOD
- Stock Information
- Founded
- CLDI 2014
- AMOD 2014
- Country
- CLDI United States
- AMOD United States
- Employees
- CLDI N/A
- AMOD N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- AMOD
- Sector
- CLDI Health Care
- AMOD
- Exchange
- CLDI Nasdaq
- AMOD NYSE
- Market Cap
- CLDI 10.2M
- AMOD 18.7M
- IPO Year
- CLDI N/A
- AMOD N/A
- Fundamental
- Price
- CLDI $0.25
- AMOD $1.16
- Analyst Decision
- CLDI
- AMOD
- Analyst Count
- CLDI 0
- AMOD 0
- Target Price
- CLDI N/A
- AMOD N/A
- AVG Volume (30 Days)
- CLDI 1.6M
- AMOD 154.6K
- Earning Date
- CLDI 08-12-2025
- AMOD 08-15-2025
- Dividend Yield
- CLDI N/A
- AMOD N/A
- EPS Growth
- CLDI N/A
- AMOD N/A
- EPS
- CLDI N/A
- AMOD 0.12
- Revenue
- CLDI N/A
- AMOD N/A
- Revenue This Year
- CLDI N/A
- AMOD N/A
- Revenue Next Year
- CLDI N/A
- AMOD N/A
- P/E Ratio
- CLDI N/A
- AMOD $9.76
- Revenue Growth
- CLDI N/A
- AMOD N/A
- 52 Week Low
- CLDI $0.20
- AMOD $1.01
- 52 Week High
- CLDI $3.89
- AMOD $13.49
- Technical
- Relative Strength Index (RSI)
- CLDI 25.04
- AMOD N/A
- Support Level
- CLDI $0.20
- AMOD N/A
- Resistance Level
- CLDI $0.24
- AMOD N/A
- Average True Range (ATR)
- CLDI 0.03
- AMOD 0.00
- MACD
- CLDI -0.00
- AMOD 0.00
- Stochastic Oscillator
- CLDI 20.46
- AMOD 0.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing, and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.